IPP Bureau
Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for cell lung cancer
By IPP Bureau - September 18, 2023
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Dr. Jitendra Singh flags off SMVD Narayana Healthcare TB Mukt Express
By IPP Bureau - September 18, 2023
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
Minister Gadkari inaugurates the Robotic Urology Centre at UroKul, Pune
By IPP Bureau - September 16, 2023
UroKul, Pune is the largest centre to conduct reconstructive urology surgery outside USA and UK
Strides receives tentative USFDA approval for Dolutegravir/Lamivudine/Tenofovir Disproxil Fumurate tablets
By IPP Bureau - September 16, 2023
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
AstraZeneca Pharma India appoints Praveen Akkinepally as Business Unit Head - Oncology
By IPP Bureau - September 16, 2023
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
Zydus receives final approval from USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System
By IPP Bureau - September 16, 2023
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Strides receives tentative USFDA approval for Dolutegravir tablets
By IPP Bureau - September 15, 2023
The products will be manufactured at the company's facility in Bengaluru
Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
By IPP Bureau - September 15, 2023
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Narayana Health unveils new brand identity
By IPP Bureau - September 15, 2023
The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity
SMi Systems secures UK patent for breakthrough single molecule imaging capabilities
By IPP Bureau - September 15, 2023
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Eye-Q launches Johnson and Johnson’s ELITA SILK procedure in India
By IPP Bureau - September 15, 2023
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
Ami Organics to supply additional API to Fermion
By IPP Bureau - September 15, 2023
The product is expected to start contributing meaningfully to the revenue from FY25
Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals
By IPP Bureau - September 14, 2023
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
Bajaj Healthcare announces receipt of EIR from USFDA
By IPP Bureau - September 14, 2023
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
Celanese inks agreement with the Population Council to supply its VitalDose drug delivery platform
By IPP Bureau - September 14, 2023
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
